Global Anti-Infective Vaccines Market Research Report 2021

Global Anti-Infective Vaccines Market Research Report 2021

Table of Contents
1 Anti-Infective Vaccines Market Overview
1.1 Product Overview and Scope of Anti-Infective Vaccines
1.2 Anti-Infective Vaccines Segment by Type
1.2.1 Global Anti-Infective Vaccines Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Inactivated Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Live/attenuated Vaccines
1.3 Anti-Infective Vaccines Segment by Application
1.3.1 Anti-Infective Vaccines Sales Comparison by Application: (2021-2027)
1.3.2 Bacterial Diseases
1.3.3 Viral Diseases
1.4 Global Anti-Infective Vaccines Market Size Estimates and Forecasts
1.4.1 Global Anti-Infective Vaccines Revenue 2016-2027
1.4.2 Global Anti-Infective Vaccines Sales 2016-2027
1.4.3 Anti-Infective Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027
2 Anti-Infective Vaccines Market Competition by Manufacturers
2.1 Global Anti-Infective Vaccines Sales Market Share by Manufacturers (2016-2021)
2.2 Global Anti-Infective Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Anti-Infective Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Anti-Infective Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Anti-Infective Vaccines Market Competitive Situation and Trends
2.5.1 Anti-Infective Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Anti-Infective Vaccines Players Market Share by Revenue
2.5.3 Global Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Infective Vaccines Retrospective Market Scenario by Region
3.1 Global Anti-Infective Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Anti-Infective Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Anti-Infective Vaccines Market Facts & Figures by Country
3.3.1 North America Anti-Infective Vaccines Sales by Country
3.3.2 North America Anti-Infective Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-Infective Vaccines Market Facts & Figures by Country
3.4.1 Europe Anti-Infective Vaccines Sales by Country
3.4.2 Europe Anti-Infective Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-Infective Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-Infective Vaccines Sales by Region
3.5.2 Asia Pacific Anti-Infective Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-Infective Vaccines Market Facts & Figures by Country
3.6.1 Latin America Anti-Infective Vaccines Sales by Country
3.6.2 Latin America Anti-Infective Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Anti-Infective Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-Infective Vaccines Sales by Country
3.7.2 Middle East and Africa Anti-Infective Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Anti-Infective Vaccines Historic Market Analysis by Type
4.1 Global Anti-Infective Vaccines Sales Market Share by Type (2016-2021)
4.2 Global Anti-Infective Vaccines Revenue Market Share by Type (2016-2021)
4.3 Global Anti-Infective Vaccines Price by Type (2016-2021)
5 Global Anti-Infective Vaccines Historic Market Analysis by Application
5.1 Global Anti-Infective Vaccines Sales Market Share by Application (2016-2021)
5.2 Global Anti-Infective Vaccines Revenue Market Share by Application (2016-2021)
5.3 Global Anti-Infective Vaccines Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Emergent BioDefense Operations Lansing Inc.
6.1.1 Emergent BioDefense Operations Lansing Inc. Corporation Information
6.1.2 Emergent BioDefense Operations Lansing Inc. Description and Business Overview
6.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Emergent BioDefense Operations Lansing Inc. Product Portfolio
6.1.5 Emergent BioDefense Operations Lansing Inc. Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sanofi Pasteur Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Merck & Co.
6.3.1 Merck & Co. Corporation Information
6.3.2 Merck & Co. Description and Business Overview
6.3.3 Merck & Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck & Co. Product Portfolio
6.3.5 Merck & Co. Recent Developments/Updates
6.4 MedImmune LLC
6.4.1 MedImmune LLC Corporation Information
6.4.2 MedImmune LLC Description and Business Overview
6.4.3 MedImmune LLC Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 MedImmune LLC Product Portfolio
6.4.5 MedImmune LLC Recent Developments/Updates
6.5 Novartis Vaccines
6.5.1 Novartis Vaccines Corporation Information
6.5.2 Novartis Vaccines Description and Business Overview
6.5.3 Novartis Vaccines Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Novartis Vaccines Product Portfolio
6.5.5 Novartis Vaccines Recent Developments/Updates
6.6 Diagnostics Ltd.
6.6.1 Diagnostics Ltd. Corporation Information
6.6.2 Diagnostics Ltd. Description and Business Overview
6.6.3 Diagnostics Ltd. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Diagnostics Ltd. Product Portfolio
6.6.5 Diagnostics Ltd. Recent Developments/Updates
6.7 Intercell Biomedical
6.6.1 Intercell Biomedical Corporation Information
6.6.2 Intercell Biomedical Description and Business Overview
6.6.3 Intercell Biomedical Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Intercell Biomedical Product Portfolio
6.7.5 Intercell Biomedical Recent Developments/Updates
6.8 MassBiologics
6.8.1 MassBiologics Corporation Information
6.8.2 MassBiologics Description and Business Overview
6.8.3 MassBiologics Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.8.4 MassBiologics Product Portfolio
6.8.5 MassBiologics Recent Developments/Updates
6.9 Barr Labs, Inc.
6.9.1 Barr Labs, Inc. Corporation Information
6.9.2 Barr Labs, Inc. Description and Business Overview
6.9.3 Barr Labs, Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Barr Labs, Inc. Product Portfolio
6.9.5 Barr Labs, Inc. Recent Developments/Updates
6.10 Organon Teknika Co.
6.10.1 Organon Teknika Co. Corporation Information
6.10.2 Organon Teknika Co. Description and Business Overview
6.10.3 Organon Teknika Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Organon Teknika Co. Product Portfolio
6.10.5 Organon Teknika Co. Recent Developments/Updates
6.11 GlaxoSmithKline Biologicals
6.11.1 GlaxoSmithKline Biologicals Corporation Information
6.11.2 GlaxoSmithKline Biologicals Anti-Infective Vaccines Description and Business Overview
6.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.11.4 GlaxoSmithKline Biologicals Product Portfolio
6.11.5 GlaxoSmithKline Biologicals Recent Developments/Updates
6.12 CSL Ltd.
6.12.1 CSL Ltd. Corporation Information
6.12.2 CSL Ltd. Anti-Infective Vaccines Description and Business Overview
6.12.3 CSL Ltd. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.12.4 CSL Ltd. Product Portfolio
6.12.5 CSL Ltd. Recent Developments/Updates
6.13 ID Biomedical Co.
6.13.1 ID Biomedical Co. Corporation Information
6.13.2 ID Biomedical Co. Anti-Infective Vaccines Description and Business Overview
6.13.3 ID Biomedical Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.13.4 ID Biomedical Co. Product Portfolio
6.13.5 ID Biomedical Co. Recent Developments/Updates
6.14 Protein Sciences Co.
6.14.1 Protein Sciences Co. Corporation Information
6.14.2 Protein Sciences Co. Anti-Infective Vaccines Description and Business Overview
6.14.3 Protein Sciences Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Protein Sciences Co. Product Portfolio
6.14.5 Protein Sciences Co. Recent Developments/Updates
6.15 Wyeth Pharmaceuticals, Inc.
6.15.1 Wyeth Pharmaceuticals, Inc. Corporation Information
6.15.2 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Description and Business Overview
6.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Wyeth Pharmaceuticals, Inc. Product Portfolio
6.15.5 Wyeth Pharmaceuticals, Inc. Recent Developments/Updates
6.16 Berna Biotech
6.16.1 Berna Biotech Corporation Information
6.16.2 Berna Biotech Anti-Infective Vaccines Description and Business Overview
6.16.3 Berna Biotech Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Berna Biotech Product Portfolio
6.16.5 Berna Biotech Recent Developments/Updates
7 Anti-Infective Vaccines Manufacturing Cost Analysis
7.1 Anti-Infective Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-Infective Vaccines
7.4 Anti-Infective Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-Infective Vaccines Distributors List
8.3 Anti-Infective Vaccines Customers
9 Anti-Infective Vaccines Market Dynamics
9.1 Anti-Infective Vaccines Industry Trends
9.2 Anti-Infective Vaccines Growth Drivers
9.3 Anti-Infective Vaccines Market Challenges
9.4 Anti-Infective Vaccines Market Restraints
10 Global Market Forecast
10.1 Anti-Infective Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-Infective Vaccines by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Anti-Infective Vaccines by Type (2022-2027)
10.2 Anti-Infective Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-Infective Vaccines by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Anti-Infective Vaccines by Application (2022-2027)
10.3 Anti-Infective Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-Infective Vaccines by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Anti-Infective Vaccines by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Anti-Infective Vaccines Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Anti-Infective Vaccines Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Anti-Infective Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Anti-Infective Vaccines Covered in This Study
Table 5. Global Anti-Infective Vaccines Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Anti-Infective Vaccines Sales Share by Manufacturers (2016-2021)
Table 7. Global Anti-Infective Vaccines Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Anti-Infective Vaccines Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Anti-Infective Vaccines Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Anti-Infective Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers Anti-Infective Vaccines Product Type
Table 12. Global Anti-Infective Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-Infective Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Infective Vaccines as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Anti-Infective Vaccines Sales by Region (2016-2021) & (K Units)
Table 16. Global Anti-Infective Vaccines Sales Market Share by Region (2016-2021)
Table 17. Global Anti-Infective Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Anti-Infective Vaccines Sales by Country (2016-2021) & (K Units)
Table 19. North America Anti-Infective Vaccines Sales Market Share by Country (2016-2021)
Table 20. North America Anti-Infective Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Anti-Infective Vaccines Revenue Market Share by Country (2016-2021)
Table 22. Europe Anti-Infective Vaccines Sales by Country (2016-2021) & (K Units)
Table 23. Europe Anti-Infective Vaccines Sales Market Share by Country (2016-2021)
Table 24. Europe Anti-Infective Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Anti-Infective Vaccines Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Anti-Infective Vaccines Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Anti-Infective Vaccines Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Anti-Infective Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Anti-Infective Vaccines Revenue Market Share by Region (2016-2021)
Table 30. Latin America Anti-Infective Vaccines Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Anti-Infective Vaccines Sales Market Share by Country (2016-2021)
Table 32. Latin America Anti-Infective Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Anti-Infective Vaccines Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Anti-Infective Vaccines Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Anti-Infective Vaccines Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Anti-Infective Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Anti-Infective Vaccines Revenue Market Share by Country (2016-2021)
Table 38. Global Anti-Infective Vaccines Sales (K Units) by Type (2016-2021)
Table 39. Global Anti-Infective Vaccines Sales Market Share by Type (2016-2021)
Table 40. Global Anti-Infective Vaccines Revenue (Million US$) by Type (2016-2021)
Table 41. Global Anti-Infective Vaccines Revenue Share by Type (2016-2021)
Table 42. Global Anti-Infective Vaccines Price (US$/Unit) by Type (2016-2021)
Table 43. Global Anti-Infective Vaccines Sales (K Units) by Application (2016-2021)
Table 44. Global Anti-Infective Vaccines Sales Market Share by Application (2016-2021)
Table 45. Global Anti-Infective Vaccines Revenue (Million US$) by Application (2016-2021)
Table 46. Global Anti-Infective Vaccines Revenue Share by Application (2016-2021)
Table 47. Global Anti-Infective Vaccines Price (US$/Unit) by Application (2016-2021)
Table 48. Emergent BioDefense Operations Lansing Inc. Corporation Information
Table 49. Emergent BioDefense Operations Lansing Inc. Description and Business Overview
Table 50. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product
Table 52. Emergent BioDefense Operations Lansing Inc. Recent Developments/Updates
Table 53. Sanofi Pasteur Corporation Information
Table 54. Sanofi Pasteur Description and Business Overview
Table 55. Sanofi Pasteur Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Sanofi Pasteur Anti-Infective Vaccines Product
Table 57. Sanofi Pasteur Recent Developments/Updates
Table 58. Merck & Co. Corporation Information
Table 59. Merck & Co. Description and Business Overview
Table 60. Merck & Co. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Merck & Co. Anti-Infective Vaccines Product
Table 62. Merck & Co. Recent Developments/Updates
Table 63. MedImmune LLC Corporation Information
Table 64. MedImmune LLC Description and Business Overview
Table 65. MedImmune LLC Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. MedImmune LLC Anti-Infective Vaccines Product
Table 67. MedImmune LLC Recent Developments/Updates
Table 68. Novartis Vaccines Corporation Information
Table 69. Novartis Vaccines Description and Business Overview
Table 70. Novartis Vaccines Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Novartis Vaccines Anti-Infective Vaccines Product
Table 72. Novartis Vaccines Recent Developments/Updates
Table 73. Diagnostics Ltd. Corporation Information
Table 74. Diagnostics Ltd. Description and Business Overview
Table 75. Diagnostics Ltd. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Diagnostics Ltd. Anti-Infective Vaccines Product
Table 77. Diagnostics Ltd. Recent Developments/Updates
Table 78. Intercell Biomedical Corporation Information
Table 79. Intercell Biomedical Description and Business Overview
Table 80. Intercell Biomedical Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Intercell Biomedical Anti-Infective Vaccines Product
Table 82. Intercell Biomedical Recent Developments/Updates
Table 83. MassBiologics Corporation Information
Table 84. MassBiologics Description and Business Overview
Table 85. MassBiologics Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. MassBiologics Anti-Infective Vaccines Product
Table 87. MassBiologics Recent Developments/Updates
Table 88. Barr Labs, Inc. Corporation Information
Table 89. Barr Labs, Inc. Description and Business Overview
Table 90. Barr Labs, Inc. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Barr Labs, Inc. Anti-Infective Vaccines Product
Table 92. Barr Labs, Inc. Recent Developments/Updates
Table 93. Organon Teknika Co. Corporation Information
Table 94. Organon Teknika Co. Description and Business Overview
Table 95. Organon Teknika Co. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Organon Teknika Co. Anti-Infective Vaccines Product
Table 97. Organon Teknika Co. Recent Developments/Updates
Table 98. GlaxoSmithKline Biologicals Corporation Information
Table 99. GlaxoSmithKline Biologicals Description and Business Overview
Table 100. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. GlaxoSmithKline Biologicals Anti-Infective Vaccines Product
Table 102. GlaxoSmithKline Biologicals Recent Developments/Updates
Table 103. CSL Ltd. Corporation Information
Table 104. CSL Ltd. Description and Business Overview
Table 105. CSL Ltd. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. CSL Ltd. Anti-Infective Vaccines Product
Table 107. CSL Ltd. Recent Developments/Updates
Table 108. ID Biomedical Co. Corporation Information
Table 109. ID Biomedical Co. Description and Business Overview
Table 110. ID Biomedical Co. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. ID Biomedical Co. Anti-Infective Vaccines Product
Table 112. ID Biomedical Co. Recent Developments/Updates
Table 113. Protein Sciences Co. Corporation Information
Table 114. Protein Sciences Co. Description and Business Overview
Table 115. Protein Sciences Co. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Protein Sciences Co. Anti-Infective Vaccines Product
Table 117. Protein Sciences Co. Recent Developments/Updates
Table 118. Wyeth Pharmaceuticals, Inc. Corporation Information
Table 119. Wyeth Pharmaceuticals, Inc. Description and Business Overview
Table 120. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product
Table 122. Wyeth Pharmaceuticals, Inc. Recent Developments/Updates
Table 123. Berna Biotech Corporation Information
Table 124. Berna Biotech Description and Business Overview
Table 125. Berna Biotech Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Berna Biotech Anti-Infective Vaccines Product
Table 127. Berna Biotech Recent Developments/Updates
Table 128. Production Base and Market Concentration Rate of Raw Material
Table 129. Key Suppliers of Raw Materials
Table 130. Anti-Infective Vaccines Distributors List
Table 131. Anti-Infective Vaccines Customers List
Table 132. Anti-Infective Vaccines Market Trends
Table 133. Anti-Infective Vaccines Growth Drivers
Table 134. Anti-Infective Vaccines Market Restraints
Table 135. Global Anti-Infective Vaccines Sales Forecast by Type (2022-2027) & (K Units)
Table 136. Global Anti-Infective Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 137. Global Anti-Infective Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 138. Global Anti-Infective Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 139. Global Anti-Infective Vaccines Sales Forecast by Application (2022-2027) & (K Units)
Table 140. Global Anti-Infective Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 141. Global Anti-Infective Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 142. Global Anti-Infective Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 143. Global Anti-Infective Vaccines Sales Forecast by Region (2022-2027) & (K Units)
Table 144. Global Anti-Infective Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 145. Global Anti-Infective Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 146. Global Anti-Infective Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Infective Vaccines
Figure 2. Global Anti-Infective Vaccines Market Share by Type in 2020 & 2027
Figure 3. Inactivated Vaccines Product Picture
Figure 4. Conjugate Vaccines Product Picture
Figure 5. Live/attenuated Vaccines Product Picture
Figure 6. Global Anti-Infective Vaccines Market Share by Application in 2020 & 2027
Figure 7. Bacterial Diseases
Figure 8. Viral Diseases
Figure 9. Global Anti-Infective Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Anti-Infective Vaccines Market Size 2016-2027 (US$ Million)
Figure 11. Global Anti-Infective Vaccines Sales 2016-2027 (K Units)
Figure 12. Global Anti-Infective Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Anti-Infective Vaccines Sales Share by Manufacturers in 2020
Figure 14. Global Anti-Infective Vaccines Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Anti-Infective Vaccines Players: Market Share by Revenue in 2020
Figure 16. Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Anti-Infective Vaccines Sales Market Share by Region (2016-2021)
Figure 18. Global Anti-Infective Vaccines Sales Market Share by Region in 2020
Figure 19. Global Anti-Infective Vaccines Revenue Market Share by Region (2016-2021)
Figure 20. Global Anti-Infective Vaccines Revenue Market Share by Region in 2020
Figure 21. U.S. Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Anti-Infective Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Anti-Infective Vaccines by Type (2016-2021)
Figure 46. Sales Market Share of Anti-Infective Vaccines by Application (2016-2021)
Figure 47. Sales Market Share of Anti-Infective Vaccines by Application in 2020
Figure 48. Revenue Share of Anti-Infective Vaccines by Application (2016-2021)
Figure 49. Revenue Share of Anti-Infective Vaccines by Application in 2020
Figure 50. Manufacturing Cost Structure of Anti-Infective Vaccines
Figure 51. Manufacturing Process Analysis of Anti-Infective Vaccines
Figure 52. Anti-Infective Vaccines Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs